Anti-Human CD34 PE-Cyanine7

Also known as: Mucosialin, Class III epitope

Clone: 4H11

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 25-0349

Cat. No. Size
25-0349-41 25 tests
25-0349-42 100 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human CD34 PE-Cy7.

Staining of normal human peripheral blood cells with Anti-Human CD45 FITC (cat. 11-0459) and Mouse...View More

  • Data for Anti-Human CD34 PE-Cy7.
Description

Description: The 4H11 monoclonal antibody reacts with human CD34, also known as mucosialin. CD34 belongs to a protein family which also includes endoglycan and podocalyxin. Members of this family are single pass transmembrane proteins with a heavily glycosylated extracellular and N-terminal mucin domain. CD34 was first identified as an antigen expressed on hematopoietic progenitors, and has since been extensively used as a marker to isolate cells capable of hematopoietic cell engraftment. In spite of this, the function of CD34 remains unresolved. In addition to expression on hematopoietic progenitors, CD34 is expressed on some populations of mesenchymal stem cells, tumor cell lines, and by vascular endothelia in the adult. Epitopes of CD34 have been assigned to three classes (class I, II or III) based on their differential sensitivity to enzymatic cleavage by neuraminidase, chymopapain, or O-glycoprotease. According to this analysis, the 4H11 antibody belongs to class III, indicating that it reacts with a protein epitope.

Details
Host Mouse
Isotype IgG1, kappa
Reactivity Human
Conjugate PE-Cyanine7
Laser Blue Laser, Green Laser, Yellow-Green Laser
Emit 775 nm
Excite 488 - 561 nm
Legal FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT # 5,268,486, 5,569,587 AND 5,627,027 AND FOREIGN EQUIVALENTS AND PENDING APPLICATIONS. THIS MATERIAL IS SUBJECT TO PROPRIETARY RIGHTS OF GE HEALTHCARE BIO-SCIENCES CORP. AND CARNEGIE MELLON UNIVERSITY AND MADE AND SOLD UNDER LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. THIS PRODUCT IS LICENSED FOR SALE ONLY FOR RESEARCH. IT IS NOT LICENSED FOR ANY OTHER USE. THERE IS NO IMPLIED LICENSE HEREUNDER FOR ANY COMMERCIAL USE. COMMERCIAL USE shall include: 1. sale, lease, license or other transfer of the material or any material derived or produced from it; 2. sale, lease, license or other grant of rights to use this Material or any material derived or produced from it; 3. use of this material to perform services for a fee for third parties. IF YOU REQUIRE A COMMERCIAL LICENSE TO USE THIS MATERIAL AND DO NOT HAVE ONE, RETURN THIS MATERIAL, UNOPENED TO EBIOSCIENCE, INC. 10255 SCIENCE CENTER DRIVE, SAN DIEGO, CALIFORNIA 92121 USA AND ANY MONEY PAID FOR THE MATERIAL WILL BE REFUNDED.
Reported Applications Flow Cytometric Analysis
Documentation
TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
17-0349 Anti-Human CD34 APC 633 - 647 nm 660 nm FC RUO
48-0349 Anti-Human CD34 eFluor® 450 405 nm 450 nm FC RUO
12-0349 Anti-Human CD34 PE 488 - 561 nm 575 nm FC RUO
11-0349 Anti-Human CD34 FITC 488 nm 518 nm FC RUO
46-0349 Anti-Human CD34 PerCP-eFluor® 710 488 nm 710 nm FC RUO
13-0349 Anti-Human CD34 Biotin FC RUO
47-0349 Anti-Human CD34 APC-eFluor® 780 633 - 647 nm 780 nm FC RUO
14-0349 Anti-Human CD34 Purified FC, FA, WB RUO
Related Products
Cat. No. Name Excite Emit Application Reg.
11-0459 Anti-Human CD45 FITC 488 nm 518 nm FC RUO
25-4714 Mouse IgG1 K Isotype Control PE-Cyanine7 488 - 561 nm 775 nm FC RUO
References

References: Elknerová K, Lacinová Z, Soucek J, Marinov I, Stöckbauer P. Growth inhibitory effect of the antibody to hematopoietic stem cell antigen CD34 in leukemic cell lines. Neoplasma. 2007;54(4):311-20. (4H11, FA, FC, PubMed)

Sutherland DR, Watt SM, Dowden G, Karhi K, Baker MA, Greaves MF, Smart JE. Structural and partial amino acid sequence analysis of the human hemopoietic progenitor cell antigen CD34. Leukemia. 1988 Dec;2(12):793-803.

Baumheter S, Singer MS, Henzel W, Hemmerich S, Renz M, Rosen SD, Lasky LA. Binding of L-selectin to the vascular sialomucin CD34. Science. 1993 Oct 15;262(5132):436-8.